| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.08 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.051 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |